{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:54:40Z","timestamp":1771062880574,"version":"3.50.1"},"reference-count":47,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"1","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: In this study, we aimed to evaluate the factors associated with disability and quality of life (QoL) in Turkish patients with systemic sclerosis (SSc).\r\nPatients and methods: Between January 2018 and January 2019, a total of 256 SSc patients (20 males, 236 females; mean age: 50.9\u00b112.4 years; range, 19 to 87 years) who were diagnosed with SSc were included in the study. Disability and health-related QoL (HRQoL) were evaluated by the Health Assessment Questionnaire (HAQ), scleroderma HAQ (SHAQ), Duru\u00f6z Hand Index (DHI), and Short Form-36 (SF-36). Linear regression analysis methods were used to describe factors associated with disability and QoL of the patients.\r\nResults: All disability scores were higher and HRQoL scores were lower in diffuse cutaneous SSc patients compared limited cutaneous SSc, and differentiations were significant (p=0.001 and p=0.007). In multiple regression, pain (VAS) was the strongest predictor for high disability and low QoL scores (p<\/jats:p>","DOI":"10.46497\/archrheumatol.2023.9243","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T16:20:11Z","timestamp":1678983611000},"page":"009-021","source":"Crossref","is-referenced-by-count":6,"title":["Association of pain and clinical factors on disability and quality of life in systemic sclerosis: A cross-sectional study from Turkish League Against Rheumatism Network"],"prefix":"10.5152","volume":"38","author":[{"family":"Remzi \u00c7evik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Serda Em","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kemal Nas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Murat Toprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Gizem Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mustafa \u00c7al\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"\u0130lhan Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ay\u015fe \u00dcnal Enginar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"P\u0131nar Bora Karsl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Sinem Sa\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bet\u00fcl Sarg\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Meltem Alkan Meliko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Y\u0131ld\u0131ray Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mehmet Tuncay Duru\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Halise Hande Gezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hilal Ecesoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3111","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Bernatsky S, Joseph L, Pineau CA, Belisle P, Hudson M, Clarke AE. Scleroderma prevalence: Demographic variations in a population-based sample. Arthritis Rheum 2009;61:400-4.","DOI":"10.1002\/art.24339"},{"key":"ref-2","unstructured":"Barnes JK, Mayes MD. Classification and epidemiology of systemic sclerosis (scleroder-ma). In: Hochberg MC, Gravallese EM, Sil-Man AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 7th ed. Philadelphia: Elsevier; 2019. p. 1231-6."},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: A systematic literature review. Semin Arthritis Rheum 2008;37:223-35.","DOI":"10.1016\/j.semarthrit.2007.05.003"},{"key":"ref-4","unstructured":"Denton CP, Ong VH. Clinical and serologic features of systemic sclerosis. In: Hochberg MC, Gravallese EM, Sil-Man AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 7th ed. Philadelphia: Elsevier; 2019. p. 1237-48."},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Zheng B, Nevskaya T, Baxter CA, Ramey DR, Pope JE, Baron M; Canadian Scleroderma Research Group. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology (Oxford) 2020;59:398-406.","DOI":"10.1093\/rheumatology\/kez299"},{"key":"ref-7","unstructured":"Schipper H, Clinch J, Powell V. Quality of life studies: Definitions and conceptual is-sues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven; 1996. p. 11-24."},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M; Canadian Scleroderma Research Group. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J Rheumatol 2009;36:768-72.","DOI":"10.3899\/jrheum.080281"},{"key":"ref-9","unstructured":"Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol 2006;33:1117-22."},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A, et al. Health-related quality of life in systemic sclerosis as measured by the Short Form 36: Relationship with clinical and biologic markers. Arthritis Rheum 2004;51:475-81.","DOI":"10.1002\/art.20389"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Johnson SR, Hawker GA, Davis AM. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: An evaluation of their measurement properties. Arthritis Rheum 2005;53:256-62.","DOI":"10.1002\/art.21084"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"Jaeger VK, Distler O, Maurer B, Czirj\u00e1k L, L\u00f3r\u00e1nd V, Valentini G, et al. Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford) 2018;57:441-50.","DOI":"10.1093\/rheumatology\/kex182"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patientgenerated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.","DOI":"10.1002\/art.1780401110"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Brower LM, Poole JL. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 2004;51:805-9.","DOI":"10.1002\/art.20701"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Li L, Cui Y, Chen S, Zhao Q, Fu T, Ji J, et al. The impact of systemic sclerosis on health-related quality of life assessed by SF-36: A systematic review and meta-analysis. Int J Rheum Dis 2018;21:1884-93.","DOI":"10.1111\/1756-185X.13438"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Bretterklieber A, Painsi C, Avian A, Wutte N, Aberer E. Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses. BMC Res Notes 2014;7:594.","DOI":"10.1186\/1756-0500-7-594"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747-55.","DOI":"10.1136\/annrheumdis-2013-eular.238"},{"key":"ref-18","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5."},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Castellv\u00ed I, Eguiluz S, Escudero-Contreras A, R\u00edos JJ, Calvo-Al\u00e9n J, Callejas-Rubio JL, et al. LAUDES Study: Impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients. Rheumatol Int 2019;39:1875-82.","DOI":"10.1007\/s00296-019-04436-z"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Georges C, Chassany O, Mouthon L, Tiev K, Toledano C, Meyer O, et al. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ). Clin Rheumatol 2005;24:3-10.","DOI":"10.1007\/s10067-004-0942-3"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, et al. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study. Rheumatology (Oxford) 2018;57:370-81.","DOI":"10.1093\/rheumatology\/kex410"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, et al. The Scleroderma Patient-Centered Intervention Network Cohort: Baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology (Oxford) 2018;57:1623-31.","DOI":"10.1093\/rheumatology\/key139"},{"key":"ref-23","unstructured":"Duru\u00f6z MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 1996;23:1167-72."},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Khanna D, Merkel PA. Outcome measures in systemic sclerosis: An update on instruments and current research. Curr Rheumatol Rep 2007;9:151-7.","DOI":"10.1007\/s11926-007-0010-5"},{"key":"ref-25","unstructured":"Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 1995;33(4 Suppl):AS264-79."},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Mouthon L, Alami S, Boisard AS, Chaigne B, Hachulla E, Poiraudeau S. Patients' views and needs about systemic sclerosis and its management: A qualitative interview study. BMC Musculoskelet Disord 2017;18:230.","DOI":"10.1186\/s12891-017-1603-4"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Cossu M, Beretta L, Mosterman P, de Hair MJH, Radstake TRDJ. Unmet needs in systemic sclerosis understanding and treatment: The knowledge gaps from a scientist's, clinician's, and patient's perspective. Clin Rev Allergy Immunol 2018;55:312-31.","DOI":"10.1007\/s12016-017-8636-1"},{"key":"ref-29","doi-asserted-by":"crossref","unstructured":"Park EH, Strand V, Oh YJ, Song YW, Lee EB. Healthrelated quality of life in systemic sclerosis compared with other rheumatic diseases: A cross-sectional study. Arthritis Res Ther 2019;21:61.","DOI":"10.1186\/s13075-019-1842-x"},{"key":"ref-30","doi-asserted-by":"crossref","unstructured":"G\u00f6k K, Erol K, Cengiz G, \u00d6zg\u00f6\u00e7men S. Comparison of level of fatigue and disease correlates in patients with rheumatoid arthritis and systemic sclerosis. Arch Rheumatol 2018;33:316-21.","DOI":"10.5606\/ArchRheumatol.2018.6670"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Herrick AL, Shukla R, Watson REB. Frontiers in translational systemic sclerosis research: A focus on the unmet 'cutaneous' clinical needs (Viewpoint). Exp Dermatol 2020;29:1144-53.","DOI":"10.1111\/exd.14179"},{"key":"ref-32","unstructured":"Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A, et al. One year in review 2019: Systemic sclerosis. Clin Exp Rheumatol 2019;37 Suppl 119:3-14."},{"key":"ref-33","unstructured":"Orlandi M, Barsotti S, Lepri G, Codullo V, Di Battista M, Guiducci S, et al. One year in review 2018: Systemic sclerosis. Clin Exp Rheumatol 2018;36 Suppl 113:3-23."},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, et al. The impact of pain and symptoms of depression in scleroderma. Pain 2002;95:267-75.","DOI":"10.1016\/S0304-3959(01)00409-2"},{"key":"ref-35","doi-asserted-by":"crossref","unstructured":"Schieir O, Thombs BD, Hudson M, Boivin JF, Steele R, Bernatsky S, et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2010;62:409-17.","DOI":"10.1002\/acr.20108"},{"key":"ref-36","doi-asserted-by":"crossref","unstructured":"Racine M, Hudson M, Baron M, Nielson WR; Canadian Scleroderma Research Group. The impact of pain and itch on functioning and health-related quality of life in systemic sclerosis: An exploratory study. J Pain Symptom Manage 2016;52:43-53.","DOI":"10.1016\/j.jpainsymman.2015.12.314"},{"key":"ref-37","doi-asserted-by":"crossref","unstructured":"Merz EL, Malcarne VL, Roesch SC, Nair DK, Salazar G, Assassi S, et al. Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: Integrating medical, psychological, and social characteristics. Qual Life Res 2017;26:85-94.","DOI":"10.1007\/s11136-016-1370-y"},{"key":"ref-38","doi-asserted-by":"crossref","unstructured":"Hughes M, Pauling JD. Exploring the patient experience of digital ulcers in systemic sclerosis. Semin Arthritis Rheum 2019;48:888-94.","DOI":"10.1016\/j.semarthrit.2018.08.001"},{"key":"ref-39","doi-asserted-by":"crossref","unstructured":"Dag A, Tarakci E, Adrovic A, Kasapcopur O. Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma. Mod Rheumatol 2021;31:657-68.","DOI":"10.1080\/14397595.2020.1816612"},{"key":"ref-40","doi-asserted-by":"crossref","unstructured":"Morrisroe K, Sudararajan V, Stevens W, Sahhar J, Zochling J, Roddy J, et al. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Rheumatology (Oxford) 2018;57:73-83.","DOI":"10.1093\/rheumatology\/kex362"},{"key":"ref-41","doi-asserted-by":"crossref","unstructured":"Sierakowska M, Sierakowski S, Sierakowska J, Krajewska-Ku\u0142ak E, Ndosi M. Pain, fatigue and functional disability are associated with higher educational needs in systemic sclerosis: A crosssectional study. Rheumatol Int 2018;38:1471-8.","DOI":"10.1007\/s00296-018-3998-0"},{"key":"ref-42","unstructured":"Deuschle K, Weinert K, Becker MO, Backhaus M, Huscher D, Riemekasten G. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Clin Exp Rheumatol 2011;29(2 Suppl 65):S53-9."},{"key":"ref-43","unstructured":"Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-40."},{"key":"ref-44","doi-asserted-by":"crossref","unstructured":"Strickland G, Pauling J, Cavill C, McHugh N. Predictors of health-related quality of life and fatigue in systemic sclerosis: Evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin Rheumatol 2012;31:1215-22.","DOI":"10.1007\/s10067-012-1997-1"},{"key":"ref-45","doi-asserted-by":"crossref","unstructured":"Budulgan M, Dilek B, Da\u011f \u015eB, Batmaz I, Y\u0131ld\u0131z \u0130, Sar\u0131y\u0131ld\u0131z MA, et al. Relationship between serum leptin level and disease activity in patients with systemic sclerosis. Clin Rheumatol 2014;33:335-9.","DOI":"10.1007\/s10067-013-2459-0"},{"key":"ref-46","unstructured":"Investigation of Body Mass Perception in Turkey. Ankara: Health Ministry Publications; 2012. p. 23."},{"key":"ref-47","doi-asserted-by":"crossref","unstructured":"Apple R, Samuels LR, Fonnesbeck C, Schlundt D, Mulvaney S, Hargreaves M, et al. Body mass index and health-related quality of life. Obes Sci Pract 2018;4:417-26.","DOI":"10.1002\/osp4.292"}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1310\/2312","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1310\/2313","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1310\/2312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:08:25Z","timestamp":1761210505000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,31]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2023.9243","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}